XT6

N/A

Report date: 2024/09/20 14:48:03
NMEFirst In Class

Base Information

Drug NameXT6
Drug Alias NameXT6XT-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitorsExtracellular-signal-regulated kinase1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors +[5] 
TargetsExtracellular-signal-regulated kinase1Serine/threonine-protein kinase AKT1Extracellular-signal-regulated kinase 2 +[5] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical UniversityNanjing University Of Chinese Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNanjing University Of Chinese MedicineChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A